Funder
Children's Discovery Institute
U.S. Department of Health & Human Services | NIH | U.S. National Library of Medicine
Publisher
Springer Science and Business Media LLC
Reference54 articles.
1. Tufail, M., Cui, J. & Wu, C. Breast cancer: molecular mechanisms of underlying resistance and therapeutic approaches. Am. J. Cancer Res. 12, 2920–2949 (2022).
2. Merikhian, P., Eisavand, M. R., & Farahmand, L. Triple-negative breast cancer: understanding Wnt signaling in drug resistance. Cancer Cell Int. 21, https://doi.org/10.1186/s12935-021-02107-3 (2021)
3. Zahedipour, F., Kesharwani, P. & Sahebkar, A. In Aptamers Engineered Nanocarriers for Cancer Therapy. 51–83 (Elsevier, 2023).
4. Shin, S. Y. & Nguyen, L. K. SynDISCO: a mechanistic modeling-based framework for predictive prioritization of synergistic drug combinations directed at cell signaling networks. Methods Mol. Biol. 2634, 357–381 (2023).
5. Bryant, K. L., Stalnecker, C. A., Zeitouni, D., Klomp, J. E., & Peng, S. et al. Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. Nat Med. https://doi.org/10.1038/s41591-019-0368-8 (2019).